Cargando…
PSUN156 Circulating thrombospondin-2 level as a novel biomarker of heart failure in type 2 diabetes
INTRODUCTION: Circulating thrombospondin-2 (TSP2) has been associated with adverse cardiovascular outcomes in patients with heart failure (HF). Type 2 diabetes (T2D) increases HF risk and induces TSP2 tissue expression. Here, we investigated prospectively the role of circulating TSP2 as a novel biom...
Autores principales: | Lee, Chi-Ho, Wu, Mei-zhen, Lui, David, Fong, Carol, Yuen, Michele, Chow, Wing-Sun, Xu, Aimin, Yiu, Kelvin, Lam, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624881/ http://dx.doi.org/10.1210/jendso/bvac150.760 |
Ejemplares similares
-
PSUN140 “Awakening of the Beta Cell(©)”
por: Jasper, Josephine, et al.
Publicado: (2022) -
PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022) -
PSUN254 Hirata's Disease - An Unexpected Surprise
por: Al-Bahadili, Huda, et al.
Publicado: (2022) -
PSUN138 Demonstration of Progressive Beta-Cell Failure in Familial Partial Lipodystrophy
por: De Freitas, Maria Foss, et al.
Publicado: (2022) -
PSUN190 Is Euglycemic Diabetic Ketoacidosis an Underrecognized Risk of SGLT2 Inhibitor Utilization?
por: Block, Romy, et al.
Publicado: (2022)